395 related articles for article (PubMed ID: 24267548)
1. Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.
Le CP; Karnezis T; Achen MG; Stacker SA; Sloan EK
Best Pract Res Clin Anaesthesiol; 2013 Dec; 27(4):409-25. PubMed ID: 24267548
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis.
Cao Z; Shang B; Zhang G; Miele L; Sarkar FH; Wang Z; Zhou Q
Biochim Biophys Acta; 2013 Dec; 1836(2):273-86. PubMed ID: 23933263
[TBL] [Abstract][Full Text] [Related]
3. New insights into the role of co-receptor neuropilins in tumour angiogenesis and lymphangiogenesis and targeted therapy strategies.
Zhao L; Chen H; Lu L; Wang L; Zhang X; Guo X
J Drug Target; 2021 Feb; 29(2):155-167. PubMed ID: 32838575
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
Harris AR; Perez MJ; Munson JM
BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis and Oxidative Stress in Metastatic Tumor Progression: Pathogenesis and Novel Therapeutic Approach of Colon Cancer.
Auyeung KK; Ko JK
Curr Pharm Des; 2017; 23(27):3952-3961. PubMed ID: 28245762
[TBL] [Abstract][Full Text] [Related]
6. Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer.
Lala PK; Nandi P; Majumder M
Cancer Metastasis Rev; 2018 Sep; 37(2-3):369-384. PubMed ID: 29858743
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
Majumder M; Xin X; Liu L; Girish GV; Lala PK
Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602
[TBL] [Abstract][Full Text] [Related]
8. The critical role of vascular endothelial growth factor in tumor angiogenesis.
Amini A; Masoumi Moghaddam S; Morris DL; Pourgholami MH
Curr Cancer Drug Targets; 2012 Jan; 12(1):23-43. PubMed ID: 22111836
[TBL] [Abstract][Full Text] [Related]
9. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis.
Schomber T; Zumsteg A; Strittmatter K; Crnic I; Antoniadis H; Littlewood-Evans A; Wood J; Christofori G
Mol Cancer Ther; 2009 Jan; 8(1):55-63. PubMed ID: 19139113
[TBL] [Abstract][Full Text] [Related]
11. Tumor lymphangiogenesis and new drug development.
Dieterich LC; Detmar M
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):148-160. PubMed ID: 26705849
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis: Managing the Culprits behind Tumorigenesis and Metastasis.
Yehya AHS; Asif M; Petersen SH; Subramaniam AV; Kono K; Majid AMSA; Oon CE
Medicina (Kaunas); 2018 Mar; 54(1):. PubMed ID: 30344239
[TBL] [Abstract][Full Text] [Related]
13. Significance and therapeutic implications of endothelial progenitor cells in angiogenic-mediated tumour metastasis.
Flamini V; Jiang WG; Lane J; Cui YX
Crit Rev Oncol Hematol; 2016 Apr; 100():177-89. PubMed ID: 26917455
[TBL] [Abstract][Full Text] [Related]
14. Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination.
Le CP; Nowell CJ; Kim-Fuchs C; Botteri E; Hiller JG; Ismail H; Pimentel MA; Chai MG; Karnezis T; Rotmensz N; Renne G; Gandini S; Pouton CW; Ferrari D; Möller A; Stacker SA; Sloan EK
Nat Commun; 2016 Mar; 7():10634. PubMed ID: 26925549
[TBL] [Abstract][Full Text] [Related]
15. Control of Gene Expression by Exosome-Derived Non-Coding RNAs in Cancer Angiogenesis and Lymphangiogenesis.
Arcucci V; Stacker SA; Achen MG
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33572413
[No Abstract] [Full Text] [Related]
16. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
17. Roles of integrins in tumor angiogenesis and lymphangiogenesis.
Garmy-Susini B; Varner JA
Lymphat Res Biol; 2008; 6(3-4):155-63. PubMed ID: 19093788
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti-angiogenic therapy.
Ambrosetti D; Coutts M; Paoli C; Durand M; Borchiellini D; Montemagno C; Rastoin O; Borderie A; Grepin R; Rioux-Leclercq N; Bernhard JC; Pagès G; Dufies M
BJU Int; 2022 Jan; 129(1):80-92. PubMed ID: 34107167
[TBL] [Abstract][Full Text] [Related]
19. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
20. Targeting the angio-proteostasis network: Combining the forces against cancer.
Devisscher L; Vieri M; Logue SE; Panse J; Geerts A; van Vlierberghe H; Chevet E; Gorman AM; Samali A; Kharabi Masouleh B
Pharmacol Ther; 2016 Nov; 167():1-12. PubMed ID: 27452337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
